Search Results 221-230 of 16454 for Pulmonary hypertension
24-week study to evaluate the efficacy and safety of macitentan for the treatment of portopulmonary hypertension. Participation eligibility. Participant ...
... pulmonary arterial hypertension. Patients will be in the study for 5 1/2 months, 4 months of which they will receive macitentan, 10 mg, once daily. The ...
Pulmonary hypertension · Pulmonary vascular complications of liver disease · Hereditary hemorrhagic telangiectasia ...
The purpose of this study is to evaluate the prevalence and effect of frailty in patients referred to pulmonary hypertension (PH) clinic at our institution.
Pulmonary hypertension is common in patients with HFpEF. Increased LA pressure adds in series with increased resistive and pulsatile pulmonary arterial loading ...
Clinical Trials · A Study Of 4D Virtual Catheter (4D VCath) For Multi-Factorial Hemodynamics In Pulmonary Hypertension · More about research at Mayo Clinic · Mayo ...
High blood pressure in the lungs, also called pulmonary hypertension. A large PDA causes irregular blood flow in the heart and lungs. · Heart failure. Symptoms ...
t-transplant care, COPD, Hepatopulmonary syndrome, Pulmonary hypertension, Pulmonary fibrosis, Cystic fibrosis, Interstitial lung disease, Pulmonary valve ...
Pulmonary arteriovenous malformation · Pulmonary fibrosis · Pulmonary hypertension; Pulmonary Langerhans cell histiocytosis; Respiratory failure; Sarcoidosis ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.